You are here

Pralatrexate

Orphan Status for Allos Drug

Yahoo/Zacks.com

Wed, 05/19/10 - 06:10 pm

FDA Approves Pralatrexate for Treatment of Peripheral T-Cell Lymphoma; Drug Discovered and Developed by SRI International, Memorial Sloan-Kettering Cancer Center, and Southern Research Institute

PR NewsWire

Sat, 09/26/09 - 11:08 am

Crucial Time for Allos Therapeutics

Yahoo/Zacks.com

Mon, 08/24/09 - 08:33 pm

Allos Therapeutics says FDA advisory committee will review lymphoma drug in September

Yahoo/AP

Mon, 08/10/09 - 11:25 am

Allos Submits Pralatrexate for FDA Approval

TheStreet.com

Wed, 03/25/09 - 04:10 pm